Search results - 197 results
New challenges in perioperative management of pancreatic cancer.
Devière; Jean-Luc Van Laethem Source: World J Gastroenterol, Volume 21, Issue 8 (2015) Keywords: Biomarkers, Tumor Carcinoma, Pancreatic Ductal Chemotherapy, Adjuvant Humans Neoadjuvant Therapy Neoplasm ...
Falls among older general practice patients: a 2-year nationwide surveillance study.
patients had received physical therapy, 47% were using assistive devices, and medication had been reviewed in 28% of patients taking psychopharmacy and 17% of patients with polypharmacy. CONCLUSIONS: Our ...
Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases.
picornaviral polyprotein is essential for viral replication. Therefore, viral proteases are attractive targets for anti-viral therapy. Most assays available for testing proteolytical activity of proteases are ...
Engineering nucleases for gene targeting: safety and regulatory considerations.
(2014) Keywords: Deoxyribonucleases Gene Targeting Genetic Therapy Humans SAFETY Abstract: Nuclease-based gene targeting (NBGT) represents a significant breakthrough in targeted genome editing since it is ...
Assessment of pfcrt 72-76 haplotypes eight years after chloroquine withdrawal in Kinshasa, Democratic Republic of Congo.
Chain Reaction Sequence Analysis, DNA Abstract: BACKGROUND: In 2001, the World Health Organization (WHO) has recommended the use of artemisinin-based combination therapy (ACT) as the first-line treatment ...
Biosafety of Gene Therapy Vectors Derived From Herpes Simplex Virus Type 14581
Publication Type: Peer reviewed scientific article Authors: Lim,F.; Khalique,H.; Ventosa,M.; Aline Baldo Source: Current Gene Therapy, Volume 13, Issue 6, Number 491, p.478- 491 (2013) ISBN: ...
Biosafety of viral vectors commonly used in gene therapy and vaccination.
Publication Type: Peer reviewed scientific article Authors: Philippe Herman Source: Curr Gene Ther, Volume 13, Issue 6, p.383-4 (2013) Keywords: Genetic Therapy Genetic Vectors Hazardous Substances ...
Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.
Animals Clinical Trials as Topic Genetic Therapy Genetic Vectors Hazardous Substances Humans Risk Assessment Vaccination vaccinia virus Viral Vaccines Abstract: The modified vaccinia virus Ankara (MVA) ...
General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination.
p.385-94 (2013) Keywords: Animals Clinical Trials as Topic Genetic Therapy Genetic Vectors Hazardous Substances Humans Organisms, Genetically Modified Risk Assessment Vaccination Viruses Abstract: This ...
The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia
POPULATION prevalence protein Rare disease REGISTRIES Registry successful Therapy UK utilization Abstract: Duchenne muscular dystrophy (DMD) is an X-linked genetic disease, caused by the absence of the ...